Triple
T12544232
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Yamanaka factors Oct3/4, Sox2, Klf4, and c-Myc |
E299919
|
entity |
| Predicate | hasMember |
P10
|
FINISHED |
| Object |
Klf4
Klf4 is a transcription factor best known as one of the four Yamanaka factors used to reprogram differentiated cells into induced pluripotent stem cells.
|
E299919
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Klf4 | Statement: [Yamanaka factors Oct3/4, Sox2, Klf4, and c-Myc, hasMember, Klf4]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Klf4 Context triple: [Yamanaka factors Oct3/4, Sox2, Klf4, and c-Myc, hasMember, Klf4]
-
A.
TARDBP
TARDBP is a gene encoding the TDP-43 protein, a DNA/RNA-binding protein whose abnormal aggregation is a key pathological feature in amyotrophic lateral sclerosis and related neurodegenerative diseases.
-
B.
Yamanaka factors
Yamanaka factors are a set of transcription factors that can reprogram adult somatic cells into induced pluripotent stem cells, revolutionizing regenerative medicine and stem cell research.
-
C.
CDK4
CDK4 is a cyclin-dependent kinase that regulates cell cycle progression and is a key therapeutic target in certain cancers.
-
D.
CDK6
CDK6 is a cyclin-dependent kinase that regulates cell cycle progression and is a key target in certain cancer therapies.
-
E.
Yamanaka factors Oct3/4, Sox2, Klf4, and c-Myc
Yamanaka factors Oct3/4, Sox2, Klf4, and c-Myc are a set of transcription factors whose forced expression can reprogram differentiated somatic cells into induced pluripotent stem cells.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Klf4 Triple: [Yamanaka factors Oct3/4, Sox2, Klf4, and c-Myc, hasMember, Klf4]
Generated description
Klf4 is a transcription factor best known as one of the four Yamanaka factors used to reprogram differentiated cells into induced pluripotent stem cells.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Klf4 Target entity description: Klf4 is a transcription factor best known as one of the four Yamanaka factors used to reprogram differentiated cells into induced pluripotent stem cells.
-
A.
TARDBP
TARDBP is a gene encoding the TDP-43 protein, a DNA/RNA-binding protein whose abnormal aggregation is a key pathological feature in amyotrophic lateral sclerosis and related neurodegenerative diseases.
-
B.
Yamanaka factors
Yamanaka factors are a set of transcription factors that can reprogram adult somatic cells into induced pluripotent stem cells, revolutionizing regenerative medicine and stem cell research.
-
C.
CDK4
CDK4 is a cyclin-dependent kinase that regulates cell cycle progression and is a key therapeutic target in certain cancers.
-
D.
CDK6
CDK6 is a cyclin-dependent kinase that regulates cell cycle progression and is a key target in certain cancer therapies.
-
E.
Yamanaka factors Oct3/4, Sox2, Klf4, and c-Myc
chosen
Yamanaka factors Oct3/4, Sox2, Klf4, and c-Myc are a set of transcription factors whose forced expression can reprogram differentiated somatic cells into induced pluripotent stem cells.
- F. None of above.
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d6ada707008190aaec1238117c9379 |
completed | April 8, 2026, 7:33 p.m. |
| NER | Named-entity recognition | batch_69d9547d6df4819080db8415d386ed38 |
completed | April 10, 2026, 7:50 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69f655801cac8190b1f9a72f8fed0399 |
completed | May 2, 2026, 7:50 p.m. |
| NEDg | Description generation | batch_69f6566f40c08190baec227fb660c948 |
completed | May 2, 2026, 7:54 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69f657aa1bf48190a884e0dfce31e30e |
completed | May 2, 2026, 7:59 p.m. |
Created at: April 8, 2026, 9:57 p.m.